(Q53085119)

11 May 2018

title

Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes. (English)

1 reference

11 May 2018

1 reference

11

1 reference

11 May 2018

Allan Flyvbjerg

5

Allan Flyvbjerg

1 reference

11 May 2018

Jonas Sieber

7

0 references

Jakob A Østergaard

Jakob A Østergaard

Coenraad Dirk Adriaan Stehouwer

4

0 references

12

Coen D A Stehouwer

1 reference

11 May 2018

Casper G. Schalkwijk

13

Casper G Schalkwijk

1 reference

11 May 2018

author name string

Olaf Brouwers

1

1 reference

11 May 2018

Petra M G Niessen

2

1 reference

11 May 2018

Toshio Miyata

3

1 reference

11 May 2018

Carine J Peutz-Kootstra

6

1 reference

11 May 2018

Peter H Mundel

8

1 reference

11 May 2018

Michael Brownlee

9

1 reference

11 May 2018

Ben J A Janssen

10

1 reference

11 May 2018

publication date

26 October 2013

1 reference

11 May 2018

published in

Diabetologia

1 reference

11 May 2018

volume

57

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

224-235

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00125-013-3088-5

exact match

0 references

cites work

Prevention and treatment of the complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Hyperglycemia and microvascular and macrovascular disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Nonenzymatic browning in vivo: possible process for aging of long-lived proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

The glyoxalase system in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Bacterial chimeras and reversible phosphorylation: the work of Walther Stoeckenius.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Mechanisms underlying endothelial dysfunction in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Methylglyoxal and methylglyoxal-arginine adducts do not directly inhibit endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Role of adhesion molecules in vascular regulation and damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

von Willebrand factor and development of diabetic nephropathy in IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Vascular complications in diabetes mellitus: the role of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Critical role for osteopontin in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Structural-functional relationships in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

The impaired renal vasodilator response attributed to endothelium-derived hyperpolarizing factor in streptozotocin--induced diabetic rats is restored by 5-methyltetrahydrofolate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3088-5

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment

21 January 2018

1 reference

12 December 2020

Development of glomerular lesions in experimental long-term diabetes in the rat

1 reference

12 December 2020

Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats

1 reference

12 December 2020

Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits

1 reference

12 December 2020

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

1 reference

12 December 2020

Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology

1 reference

12 December 2020

Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody

1 reference

12 December 2020

Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate

1 reference

12 December 2020

A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes

1 reference

12 December 2020

Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen

1 reference

12 December 2020

Endothelial cells in physiology and in the pathophysiology of vascular disorders

1 reference

12 December 2020

Quantitative UPLC-MS/MS analysis of underivatised amino acids in body fluids is a reliable tool for the diagnosis and follow-up of patients with inborn errors of metabolism

1 reference

12 December 2020

The assay of S-D-lactoylglutathione in biological systems

1 reference

12 December 2020

N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats

1 reference

12 December 2020

Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals

1 reference

12 December 2020

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

1 reference

12 December 2020

10.1007/S00125-013-3088-5

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

24162587

1 reference

11 May 2018